The oral bioavailability of Trimethobenzamide is 60% to 100%
Currently GDC-0349 is in Phase I clinical trials to evaluate the safety and tolerability in patients with locally advanced or metastatic solid tumors or Non-Hodgkin's lymphoma
LY 2835219
Small molecule allosteric modulation of the glucagon-like Peptide-1 receptor enhances the insulinotropic effect of oxyntomodulin
InChiKey: LGGHDPFKSSRQNS-UHFFFAOYSA-N
Quassin (hemihydrate) The oral bioavailability of TrimethobenzamideQuassin (Nigakilactone D) is a bioactive triterpenoid from stem bark extract of Quassia amara. Quassin inhibits P. falciparum with an IC50 of 0. 15 M. Quassin possesses reversible antifertility, anti estrogenic and anti plasmodial activity. Product information CAS Number: 76 78 8 Molecular Weight: 388. 45 Formula: C22H28O6 Chemical Name: (3aR, 3a1S, 6aR, 7aS, 8S, 11aS, 11bS) 2, 10 dimethoxy 3, 3a1, 8, 11a tetramethyl 3a, 4, 6a, 7, 7a, 8, 11a, 11b